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stimulatory effect of AT1 receptor on Na+-K+ ATPase activity in SHR
cells.
CONCLUSIONS We suggest that a differential interaction between D4
and AT1 receptors may play a role in the differential regulation of
sodium excretion and blood pressure in hypertension.
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OBJECTIVES To investigate the electrophysiological mechanisms of
mutated cardiac L-type calcium channel (LTCC) caused by a CACNA1C
gene mutation in ER from cellular level, and screening of effective
drug treatment.
METHODS Patients with early repolarization syndrome (ERS) were
recruited according to the 2013 HRS/EHRA/APHRS diagnostic expert
consensus statement. Mutation analysis was detected by direct
sequencing. HEK293 cells were co-transfected with wild type or
mutant human CACNA1C, and its auxiliary unit contained CACNB2b
and CACNA2D1 for the cellular electrophysiological and drug inter-
vention study of LTCC.
RESULTS A missense mutation in CACNA1C gene (c.5747A > G,
p.Q1916R) was identiﬁed in a 34-year-old male patient. The mutant L-
type calcium current (ICa-L) in HEK293 cells declined when compared
to the wild calcium channel, (P＜0.05, P＜0.01), there is no difference
of the voltage dependent SSA between the 2 groups. The testosterone
(10 mM) signiﬁcantly reduces the current density (P ＜0.05). The
therapeutic drug for ERS of isoproterenol (10 mM) increases the wild
calcium current density, while the increased mutant calcium current
density without statistical signiﬁcance. The quinidine (5 mM) has no
any effect on the calcium current density and voltage dependent SSA
in the both groups.
CONCLUSIONS In conclusion, a novel CACNA1C mutation might be
associated with the ERS. The CACNA1C-Q1916R is a loss-of-function
mutation with decreased calcium current. The testosterone exacer-
bates the decreased CACNA1C-Q1916R mutant calcium current den-
sity, which suggests that the male gender is an important risk factor
ERS. There might be no therapeutic effect of isoproterenol in the
CACNA1C-Q1916R mutant carrier related to the early repolarization we
studied here.
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OBJECTIVES Hypertension is one of the major risk factors for
developing cardiac hypertrophy and heart failure. Although cellular
signaling pathways, intracellular Ca2+ handling and myoﬁlament
Ca2+ sensitivity are known to be altered in hypertensive myocar-
dium, mechanisms mediating left ventricular (LV) contractile func-
tion remain to be deﬁned. It is known that neuronal nitric oxide
synthase (nNOS) is up-regulated in hypertensive myocardium,
however, its role in myocyte Ca2+ handling and myoﬁlament Ca2+
sensitivity and their interplays in regulating contractile function is
not clear. Therefore, we aim to test the functional regulation by
nNOS of LV myocyte contraction in angiotensin II (Ang II)-induced
hypertensive rats.
METHODS Sprague-Dawley rats (8 weeks old, male) were subjected to
Ang II infusion subcutaneously using osmotic minipump for 4 weeks
(125ng/min/kg). These animals were paired with sham-operated
groups. LV myocytes were isolated using a standard enzymatic
dispersion technique. Contraction and relaxation were measured in
LV myocytes (ﬁeld-stimulation at 2 Hz, 361oC) by using a video-
sarcomere detection system (IonOptix Corp).RESULTS Systemic blood pressure was elevated in Ang II-treated
rats (osmotic minipump, 4 weeks) compared to that in shams.
Functional analysis showed that LV myocyte sarcomere shortening
was unchanged and relaxation was faster in Ang II-rats compared to
those from shams. L-type Ca2+ channel activity (ICa) was not
different between two groups, however, peak [Ca2+]i was increased
(Fura 2, F360/F380) and decay of [Ca2+]i (tau) was faster in Ang II-
rats. These changes were accompanied by reduced myoﬁlament
Ca2+ sensitivity (EC50). Immunoblotting results revealed that nNOS
protein expression was signiﬁcantly increased (optical density of
nNOS/GAPDH) in LV myocyte homogenates from Ang II-rats. Inhi-
bition of nNOS with speciﬁc inhibitors, S-methyl-L-thiocitrulline
(SMTC, 100 nM) or N5-(1-Imino-3-butenyl)-L-ornithine (L-VNIO,
100 uM) restored myoﬁlament Ca2+ sensitivity and reduced [Ca2+]i
in Ang II-rats. As a result, LV myocyte contraction was maintained
unaltered. Interestingly, ICa was increased by nNOS inhibition
(similar to that in sham) but tau of [Ca2+]i was not affected, despite
that relaxation was signiﬁcantly prolonged by SMTC or L-VNIO in
Ang II-rats. A speciﬁc inhibitor of protein kinase G (KT 5823, 1 uM)
mimicked the effect of nNOS and increased myoﬁlament Ca2+
sensitivity, [Ca2+]i and LV myocyte contraction.
CONCLUSIONS These results suggest that reduced myoﬁlament
Ca2+ sensitivity by nNOS plays predominant role in controlling
intracellular Ca2+ handling and LV myocyte contractility in hyper-
tension.GW26-e4492
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OBJECTIVES Ultrasound combined with endogenous protoporphy-
rin IX derived from 5- aminolevulinic acid (ALA-SDT) is known to
induce apoptosis in multiple cancer cells and macrophages. Persis-
tent retention of macrophages in the plaque has been implicated
in the pathophysiology and progression of atherosclerosis. Here
we investigated the effects of inhibition of voltage-dependent
anion channel 1 (VDAC1) on ALA-SDT-induced THP-1 macrophages
apoptosis.
METHODS Cells were pre-treated with VDAC1 inhibitor 4, 4’ -diiso-
thiocyanostilbene-2, 2’ -disulfonic acid (DIDS) disodium salt for 1 h
or downregulated VDAC1 expression by small interfering RNA and
exposed to ultrasound. Cell viability was assessed by MTT assay,
and cell apoptosis along with necrosis was evaluated by Hoechst
33342/ propidium iodide staining and ﬂow cytometry. Levels of cy-
tochrome c release was assessed by confocal microscope and West-
ern blot. The levels of full length caspases, caspase activation, and
VDAC isoforms were analyzed by Western blot. Intracellular reactive
oxygen species generation, mitochondrial membrane permeability,
and intracellular Ca2+ ([Ca2+]i) levels were measured with ﬂuorescent
probes.
RESULTS The pharmacological inhibition of VDAC1 by DIDS notably
prevented ALA-SDT-induced cell apoptosis in THP-1 macrophages.
DIDS signiﬁcantly inhibited intracellular ROS generation and
apoptotic biochemical changes such as inner mitochondrial mem-
brane permeabilization, loss of mitochondrial membrane potential,
cytochrome c release and activation of caspase-3 and caspase-9.
Moreover, ALA-SDT elevated the [Ca2+]i levels and it was also
notably reduced by DIDS. Furthermore, both of intracellular ROS
generation and cell apoptosis were predominately inhibited by Ca2+
chelating reagent BAPTA-AM. Intriguingly, ALA-treatment markedly
augmented VDAC1 protein levels exclusively, and the down-
regulation of VDAC1 expression by speciﬁc siRNA also signiﬁcantly
abolished cell apoptosis.
CONCLUSIONS VDAC1 plays a crucial role in ALA-SDT-induced THP-1
macrophages apoptosis, and targeting VDAC1 is a potential way
regulating macrophages apoptosis. This ﬁnding may be relevant to
therapeutic strategies against atherosclerosis.
